Nothing Special   »   [go: up one dir, main page]

This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1973 1
1977 2
1979 1
1980 1
1982 3
1983 2
1985 1
1986 3
1987 1
1988 1
1989 3
1990 6
1991 7
1992 12
1993 4
1994 17
1995 16
1996 23
1997 28
1998 31
1999 38
2000 53
2001 40
2002 55
2003 56
2004 84
2005 114
2006 164
2007 170
2008 214
2009 287
2010 306
2011 373
2012 501
2013 597
2014 748
2015 826
2016 903
2017 973
2018 1266
2019 1449
2020 1842
2021 2137
2022 2602
2023 2513
2024 2514
2025 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18,797 results

Results by year

Filters applied: . Clear all
Page 1
Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension.
Desai AS, Webb DJ, Taubel J, Casey S, Cheng Y, Robbie GJ, Foster D, Huang SA, Rhyee S, Sweetser MT, Bakris GL. Desai AS, et al. Among authors: cheng y. N Engl J Med. 2023 Jul 20;389(3):228-238. doi: 10.1056/NEJMoa2208391. N Engl J Med. 2023. PMID: 37467498 Clinical Trial.
Akkermansia muciniphila in neuropsychiatric disorders: friend or foe?
Lei W, Cheng Y, Gao J, Liu X, Shao L, Kong Q, Zheng N, Ling Z, Hu W. Lei W, et al. Among authors: cheng y. Front Cell Infect Microbiol. 2023 Jul 10;13:1224155. doi: 10.3389/fcimb.2023.1224155. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37492530 Free PMC article. Review.
Envonalkib versus crizotinib for treatment-naive ALK-positive non-small cell lung cancer: a randomized, multicenter, open-label, phase III trial.
Yang Y, Min J, Yang N, Yu Q, Cheng Y, Zhao Y, Li M, Chen H, Ren S, Zhou J, Zhuang W, Qin X, Cao L, Yu Y, Zhang J, He J, Feng J, Yu H, Zhang L, Fang W. Yang Y, et al. Among authors: cheng y. Signal Transduct Target Ther. 2023 Aug 14;8(1):301. doi: 10.1038/s41392-023-01538-w. Signal Transduct Target Ther. 2023. PMID: 37574511 Free PMC article. Clinical Trial.
18,797 results
You have reached the last available page of results. Please see the User Guide for more information.